Research programme: influenza therapeutics - NEOMED/University of Sherbrooke
Latest Information Update: 08 Oct 2013
At a glance
- Originator Institut de pharmacologie de Sherbrooke; NEOMED; University of Sherbrooke
- Mechanism of Action Serine protease inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Influenza virus infections
Most Recent Events
- 26 Sep 2013 Early research in Influenza virus infections in Canada (unspecified route)